Related Experiment Video

Updated: Jun 14, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

CNK1 is a novel Akt interaction partner that promotes cell proliferation through the Akt-FoxO signalling axis

R D Fritz1, Z Varga, G Radziwill

  • 1Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Oncogene
|April 13, 2010
PubMed

Insights

Connector enhancer of KSR (CNK1) protein promotes breast cancer cell proliferation by activating the Akt-FoxO pathway. CNK1 overexpression stimulates growth, while its downregulation inhibits it, highlighting its oncogenic role.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Scaffold proteins like connector enhancer of KSR (CNK) are involved in key cellular signaling pathways.
  • CNK proteins regulate processes such as cell differentiation and invasion.
  • The specific role of CNK1 in cancer proliferation requires further elucidation.

Purpose of the Study:

  • To investigate the role of CNK1 in the proliferation of breast cancer cells.
  • To determine the signaling pathways through which CNK1 influences cell growth.
  • To examine the subcellular localization of CNK1 in normal and cancerous breast cells.

Main Methods:

  • Cell proliferation assays (CNK1 downregulation/overexpression).
  • Pharmacological inhibition of phosphatidylinositol-3 kinase (PI3K) pathway.
  • Western blotting to assess Akt and FoxO activity.
  • Immunofluorescence and immunohistochemistry for CNK1 localization.
  • Analysis of clinical breast cancer samples.

Main Results:

  • CNK1 overexpression stimulates, while CNK1 downregulation inhibits, breast cancer cell proliferation.
  • CNK1-induced proliferation is dependent on the PI3K/Akt pathway.
  • CNK1 interacts with Akt, modulating its activity and downstream FoxO phosphorylation.
  • CNK1 is localized at the plasma membrane in breast cancer cells and tumors, unlike in normal cells.
  • Reduced Akt activity is observed in CNK1-negative breast tumors.

Conclusions:

  • CNK1 acts as a positive regulator of breast cancer cell proliferation.
  • CNK1 promotes oncogenic signaling via the Akt pathway in breast cancer.
  • CNK1's plasma membrane localization correlates with its pro-proliferative function in breast cancer.

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...